Literature DB >> 33538947

Human PRV Infection in China: An Alarm to Accelerate Eradication of PRV in Domestic Pigs.

Zhenhua Guo1, Xin-Xin Chen1, Gaiping Zhang2,3.   

Abstract

Entities:  

Year:  2021        PMID: 33538947     DOI: 10.1007/s12250-021-00347-1

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


× No keyword cloud information.
  4 in total

1.  Clinical Utility of In-house Metagenomic Next-generation Sequencing for the Diagnosis of Lower Respiratory Tract Infections and Analysis of the Host Immune Response.

Authors:  Hongbin Chen; Yuyao Yin; Hua Gao; Yifan Guo; Zhao Dong; Xiaojuan Wang; Yawei Zhang; Shuo Yang; Qiusheng Peng; Yudong Liu; Hui Wang
Journal:  Clin Infect Dis       Date:  2020-12-23       Impact factor: 9.079

2.  Detection of Pseudorabies Virus Antibodies in Human Encephalitis Cases.

Authors:  Xiang Dong Li; Shi Hong Fu; Ling Yan Chen; Fan Li; Jun Hua Deng; Xuan Cheng Lu; Huan Yu Wang; Ke Gong Tian
Journal:  Biomed Environ Sci       Date:  2020-06-20       Impact factor: 3.118

3.  [Clinical experience and next-generation sequencing analysis of encephalitis caused by pseudorabies virus].

Authors:  W L Zhao; Y H Wu; H F Li; S Y Li; S Y Fan; H L Wu; Y J Li; Y L Lü; J Han; W C Zhang; Y Zhao; G L Li; X D Qiao; H T Ren; Y C Zhu; B Peng; L Y Cui; H Z Guan
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2018-04-17

4.  Ocular Manifestations and Clinical Implications of Serum Immunoglobulin G4 Levels in Graves' Ophthalmopathy Patients.

Authors:  Ban Luo; Xu Yuan; Wei Wang; Jing Zhang; Rong Liu; Weikun Hu; Xin Qi; Nan Xiang; Liwen Chen
Journal:  Ocul Immunol Inflamm       Date:  2020-10-15       Impact factor: 3.728

  4 in total
  8 in total

1.  Acute transcriptomic changes in murine RAW 264.7 cells following pseudorabies virus infection.

Authors:  Chao Tong; Peng-Fei Fu; Sheng-Li Ming; Lei Zeng; He-Shui Zhu; Jiang Wang
Journal:  Arch Virol       Date:  2022-10-21       Impact factor: 2.685

2.  PCV2 and PRV Coinfection Induces Endoplasmic Reticulum Stress via PERK-eIF2α-ATF4-CHOP and IRE1-XBP1-EDEM Pathways.

Authors:  Si Chen; Xue Li; Xinwei Zhang; Guyu Niu; Lin Yang; Weilong Ji; Liying Zhang; Linzhu Ren
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

3.  Human Encephalitis Complicated With Ocular Symptoms Associated With Pseudorabies Virus Infection: A Case Report.

Authors:  Liu Yue; Li Yi; Tong Fei; Tian MengWu; Li Man; Wang LiQing; Zou YueLi; Duan JiaLiang; Bu Hui; He JunYing
Journal:  Front Neurol       Date:  2022-05-09       Impact factor: 4.086

4.  Epidemiological Investigation and Genetic Analysis of Pseudorabies Virus in Yunnan Province of China from 2017 to 2021.

Authors:  Jun Yao; Juan Li; Lin Gao; Yuwen He; Jiarui Xie; Pei Zhu; Ying Zhang; Xue Zhang; Luoyan Duan; Shibiao Yang; Chunlian Song; Xianghua Shu
Journal:  Viruses       Date:  2022-04-25       Impact factor: 5.818

5.  Functional Analysis of a Frontal miRNA Cluster Located in the Large Latency Transcript of Pseudorabies Virus.

Authors:  Weronika Hoffmann; Andrea D Lipińska; Krystyna Bieńkowska-Szewczyk
Journal:  Viruses       Date:  2022-05-26       Impact factor: 5.818

6.  Mutation and Interaction Analysis of the Glycoprotein D and L and Thymidine Kinase of Pseudorabies Virus.

Authors:  Xue Li; Si Chen; Liying Zhang; Jiawei Zheng; Guyu Niu; Lin Yang; Xinwei Zhang; Linzhu Ren
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

7.  Pseudorabies in pig industry of China: Epidemiology in pigs and practitioner awareness.

Authors:  Lei Tan; Yujun Zhou; Yixing Qiu; Lei Lei; Cheng Wang; Pei Zhu; Deyong Duan; Hongyu Lei; Lincheng Yang; Naidong Wang; Yi Yang; Jun Yao; Wei Wang; Aibing Wang
Journal:  Front Vet Sci       Date:  2022-09-16

Review 8.  A Tug of War: Pseudorabies Virus and Host Antiviral Innate Immunity.

Authors:  Guangqiang Ye; Hongyang Liu; Qiongqiong Zhou; Xiaohong Liu; Li Huang; Changjiang Weng
Journal:  Viruses       Date:  2022-03-06       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.